Menu

Voyager Therapeutics, Inc. VYGR

Full chart Compare
Set alert

Price alert · VYGR

All alert types
1.87 USD +0.15 (+8.43%)

At closeNov 6, 2026, 5:24 PM EST

1.83 -0.03 -1.88%

After hours · Nov 6, 5:24 PM ET

1.72 Day range 1.96
1.72 52-week range 5.00
YTD
-52.54%
1 year
-55.81%

Revenue & Expenses

Other Income → Expenses: $12.27MExpenses → Gross Loss: $91.90MExpenses → Selling, General & Admin: $36.44MExpenses → Research & Development: $134.67MExpenses → Income Tax: $144.00KOther Operating Income → Expenses: $131.17MNet Loss → Expenses: $119.72MRevenue → Cost of Revenue: $40.37MOther Income$12.27MOther Operating Income$131.17MNet Loss$119.72MCost of Revenue$132.27MExpenses$263.16MGross Loss$91.90MSelling, General & Admin$36.44MResearch & Development$134.67MIncome Tax$144.00KRevenue$40.37M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

VYGR annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
40.37M80.00M250.01M40.91M37.41M
40.37M80.00M250.01M40.91M37.41M
40.37M80.00M250.01M40.91M37.41M
172.22M163.29M127.99M91.74M111.03M
134.67M127.37M92.17M60.76M73.79M
37.54M35.92M35.82M30.98M37.25M
-131.84M-83.29M122.01M-50.84M-73.62M
144.00K665.00K1.41M16.00K0
-119.72M-65.00M132.33M-46.41M-71.20M
-119.72M-65.00M132.33M-46.41M-71.20M
-119.72M-65.00M132.33M-46.41M-71.20M
-119.72M-65.00M132.33M-46.41M-71.20M
-2.04-1.133.08-1.21-1.89
-2.04-1.133.08-1.21-1.89
-2.04-1.132.97-1.21-1.89
-119.58M-64.34M133.74M-46.39M-70.81M
-119.58M-64.34M133.74M-46.39M-70.81M
58.69M57.67M43.02M38.36M37.67M
58.69M57.67M44.57M38.36M37.67M